Ventyx Biosciences, Inc.

Historical 13F Holders

Symbol
VTYX
CUSIP
92332V107
All holders as of
Q2 2025
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Filings
Period Filings Shares, Excl. Options Value, Excl. Options
2025 Q2 118 44.5 M $95.2 M
2025 Q1 123 44.4 M $51.1 M
2024 Q4 131 54.5 M $119 M
2024 Q3 125 53.5 M $117 M
2024 Q2 127 58.9 M $136 M
2024 Q1 136 62.7 M $344 M
2023 Q4 132 46.7 M $115 M
2023 Q3 160 56.6 M $1.97 B
2023 Q2 165 55.0 M $1.80 B
2023 Q1 161 51.2 M $1.71 B
2022 Q4 136 45.0 M $1.47 B
2022 Q3 113 40.6 M $1.42 B
2022 Q2 64 34.6 M $424 M
2022 Q1 56 33.2 M $448 M
2021 Q4 47 31.6 M $619 M